Interleukin-1 receptor antagonist anakinra proves long-lasting efficacy in the treatment of refractory adult onset still's disease

被引：0
|
作者：
Naumann, L. [1 ]
Feist, E. [1 ]
Natusch, A. [2 ]
Krause, A. [2 ]
Buttgereit, F. [1 ]
Burmester, G. [1 ]
机构：
[1] Univ Berlin Med, Charite, Berlin, Germany
[2] Univ Berlin Med, Charite, Clin Rheumatol Berlin Buch & Immanuel Krankenhaus, Berlin, Germany
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2007年 / 66卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：434 / 435
页数：2
相关论文
共 50 条
  • [41] Anakinra (recombinant interleukin-1 receptor antagonist): A large, placebo controlled efficacy trial of anakinra in patients with erosive rheumatoid arthritis disease
    Cohen, SB
    Moreland, LW
    Cush, JJ
    Greenwald, MW
    Block, JA
    Shergy, WJ
    Hanrahan, PS
    Khraishi, MM
    Patel, A
    Sun, G
    Bear, M
    ARTHRITIS AND RHEUMATISM, 2001, 44 (12): : 2946 - 2946
  • [42] Interleukin-1 Receptor Antagonist Reduces Neonatal Lipopolysaccharide-Induced Long-Lasting Neurobehavioral Deficits and Dopaminergic Neuronal Injury in Adult Rats
    Pang, Yi
    Tien, Lu-Tai
    Zhu, Hobart
    Shen, Juying
    Wright, Camilla F.
    Jones, Tembra K.
    Mamoon, Samir A.
    Bhatt, Abhay J.
    Cai, Zhengwei
    Fan, Lir-Wan
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2015, 16 (04): : 8635 - 8654
  • [43] Efficacy of Anti-Interleukin-1 Receptor Antagonist Anakinra (Kineret®) in a Case of Refractory Sweet's Syndrome
    Kluger, Nicolas
    Gil-Bistes, Deborah
    Guillot, Bernard
    Bessis, Didier
    DERMATOLOGY, 2011, 222 (02) : 123 - 127
  • [44] Interleukin-1 Inhibitors and Dacryoadenitis in Adult-Onset Still Disease
    Breillat, Paul
    Tourte, Maylis
    Romero, Pierre
    Hayem, Gilles
    Padovano, Ilaria
    Costantino, Felicie
    Breban, Maxime
    ANNALS OF INTERNAL MEDICINE, 2018, 168 (06) : 455 - +
  • [45] Post-infection immunocomplex glomerulonephritis and Legionnaires' disease in a patient with adult Still's disease during treatment with interleukin 1 receptor antagonist anakinra: A case report
    Scholtze D.
    Varga Z.
    Imhof A.
    Journal of Medical Case Reports, 5 (1)
  • [46] Effectiveness of anakinra in the treatment of chronic active adult onset Still's disease
    Vogt, T.
    Daikeler, T.
    Tyndall, A.
    SWISS MEDICAL WEEKLY, 2007, 137 : 10S - 10S
  • [47] The Interleukin-1 Receptor Antagonist Anakinra Is Effective In The Treatment Of Undifferentiated Periodic Fever Syndromes
    Schwartz, Daniella M.
    Wang, Runsheng
    Barron, Karyl S.
    Kastner, Daniel L.
    Ombrello, Amanda K.
    ARTHRITIS AND RHEUMATISM, 2013, 65 : S926 - S927
  • [48] Efficacy of Anakinra in Refractory Adult-Onset Still's Disease Multicenter Study of 41 Patients and Literature Review
    Ortiz-Sanjuan, Francisco
    Blanco, Ricardo
    Riancho-Zarrabeitia, Leyre
    Castaneda, Santos
    Olive, Alejandro
    Riveros, Anne
    Velloso-Feijoo, Maria L.
    Narvaez, Javier
    Jimenez-Moleon, Inmaculada
    Maiz-Alonso, Olga
    Ordonez, Carmen
    Bernal, Jose A.
    Hernandez, Maria V.
    Sifuentes-Giraldo, Walter A.
    Gomez-Arango, Catalina
    Galindez-Agirregoikoa, Eva
    Blanco-Madrigal, Juan
    Ortiz-Santamaria, Vera
    del Blanco-Barnusell, Jordi
    De Dios, Juan R.
    Moreno, Mireia
    Fiter, Jordi
    de los Riscos, Marina
    Carreira, Patricia
    Rodriguez-Valls, Maria J.
    Gonzalez-Vela, M. Carmen
    Calvo-Rio, Vanesa
    Loricera, Javier
    Palmou-Fontana, Natalia
    Pina, Trinitario
    Llorca, Javier
    Gonzalez-Gay, Miguel A.
    MEDICINE, 2015, 94 (39) : e1554
  • [49] Anakinra should be first line treatment for adult onset Still's disease
    Moore, Sarah
    Fitzgerald, Jonathan
    Kallarackal, George
    RHEUMATOLOGY, 2008, 47 : II164 - II164
  • [50] Interleukin 1 inhibition with anakinra in adult-onset Still disease: a meta-analysis of its efficacy and safety
    Hong, Dongsheng
    Yang, Zhihai
    Han, Shuyin
    Liang, Xingguang
    Ma, Kuifen
    Zhang, Xingguo
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2014, 8 : 2345 - 2357
12345